91 related articles for article (PubMed ID: 1589701)
1. Lipid profile in 100 men with moderate hypertension treated for 1 year with atenolol or hydrochlorothiazide plus amiloride: a double-blind, randomized study.
Otterstad JE; Froeland G; Soeyland AK; Illingworth JM
Scand J Clin Lab Invest; 1992 Apr; 52(2):83-93. PubMed ID: 1589701
[TBL] [Abstract][Full Text] [Related]
2. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
3. Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients.
Corea L; Bentivoglio M; Verdecchia P
Int J Clin Pharmacol Res; 1983; 3(5):367-70. PubMed ID: 6678830
[TBL] [Abstract][Full Text] [Related]
4. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
5. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
6. Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients.
Ahaneku JE; Taylor GO; Agbedana OE; Walker O; Salako LA
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):155-60. PubMed ID: 7701530
[TBL] [Abstract][Full Text] [Related]
7. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
López NC; Corral JL; Rincón LA; Arreaza MR; Giralt J; Galué GA; Barrios YE; Arocha I
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S101-5. PubMed ID: 1723446
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
9. Comparison of low doses of hydrochlorothiazide plus amiloride and hydrochlorothiazide alone in hypertension in elderly patients.
Salmela PI; Juustila H; Kinnunen O; Koistinen P
Ann Clin Res; 1986; 18(2):88-92. PubMed ID: 3521443
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
[TBL] [Abstract][Full Text] [Related]
11. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
Lacourcière Y; Gagné C
J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
[TBL] [Abstract][Full Text] [Related]
12. Hypertension in the elderly: a study of a combination of atenolol, hydrochlorothiazide and amiloride hydrochloride.
Duckett GK; Cheadle B
Br J Clin Pract; 1990 Sep; 44(9):354-8. PubMed ID: 2223528
[TBL] [Abstract][Full Text] [Related]
13. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group.
Arch Intern Med; 1981 Mar; 141(4):482-6. PubMed ID: 7011237
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
15. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
[TBL] [Abstract][Full Text] [Related]
16. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular end-diastolic dimensions measured at the P wave and Q wave during a randomized, double-blind one-year follow-up study comparing the effect of atenolol vs. hydrochlorothiazide + amiloride on blood pressure in men with mild to moderate hypertension.
Otterstad JE; Froeland G; Erikssen J
Scand J Clin Lab Invest; 1993 Apr; 53(2):155-62. PubMed ID: 8469914
[TBL] [Abstract][Full Text] [Related]
19. Amiloride with or without salbutamol versus placebo: effects on lipoproteins in hypertensive patients treated with timolol-hydrochlorothiazide.
Spence JD; Wong DG
J Hypertens Suppl; 1986 Dec; 4(5):S515-8. PubMed ID: 3553482
[TBL] [Abstract][Full Text] [Related]
20. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Damian DJ; McNamee R; Carr M
BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
